Onconova Therapeutics
Newtown
About Onconova Therapeutics
Onconova Therapeutics, is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $177.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2021)
- Ticker: nasdaq:ONTX
- Website: onconova.com
- Phone: +1-267-759-3680
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/onconova-therapeutics-157429 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.